KIMS

Krishna Institute of Medical Sciences Share Price

 

 

Invest in Krishna Institute of Medical Sciences with 3.46X leverage

Invest with MTF

Performance

  • Low
  • ₹652
  • High
  • ₹667
  • 52 Week Low
  • ₹474
  • 52 Week High
  • ₹798
  • Open Price₹667
  • Previous Close₹663
  • Volume181,370

Investment Returns

  • Over 1 Month -5.61%
  • Over 3 Month -12.44%
  • Over 6 Month + 1.69%
  • Over 1 Year + 7.6%

Smart Investing Starts Here Start SIP with Krishna Institute of Medical Sciences for Steady Growth!

Invest Now

Krishna Institute of Medical Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 78.8
  • PEG Ratio
  • 55.7
  • Market Cap Cr
  • 26,475
  • P/B Ratio
  • Average True Range
  • 19.98
  • EPS
  • 8.21
  • Dividend Yield
  • 0
  • MACD Signal
  • -5.18
  • RSI
  • 37.31
  • MFI
  • 47.68

Krishna Institute of Medical Sciences Financials

Krishna Institute of Medical Sciences Technicals

EMA & SMA

Current Price
₹661.65
-1.55 (-0.23%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹687.80
  • 50 Day
  • ₹699.06
  • 100 Day
  • ₹701.07
  • 200 Day
  • ₹675.02

Resistance and Support

670.73 Pivot Speed
  • R3 707.47
  • R2 697.73
  • R1 680.47
  • S1 653.47
  • S2 643.73
  • S3 626.47

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Krishna Institute of Medical Sciences Ltd. (KIMS) is a leading healthcare provider in India, operating a network of multi-specialty hospitals. It offers high-quality medical care across various specialties, serving patients in both urban and rural regions.

Krishna Institute Of Medical Sciences has an operating revenue of Rs. 3,401.60 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 18% is great, ROE of 17% is exceptional. The company has a debt to equity of 77%, which is bit higher. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at D+ which indicates heavy supply, Group Rank of 53 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Krishna Institute of Medical Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-07 Quarterly Results
2025-08-06 Quarterly Results
2025-05-12 Audited Results
2025-02-06 Quarterly Results
2024-11-09 Quarterly Results
Date Purpose Remarks
2024-09-13 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

Krishna Institute of Medical Sciences F&O

Krishna Institute of Medical Sciences Shareholding Pattern

34.11%
26.72%
5.04%
15.03%
0%
11.72%
7.38%

About Krishna Institute of Medical Sciences

  • NSE Symbol
  • KIMS
  • BSE Symbol
  • 543308
  • Chairman & Managing Director
  • Dr. Bhaskara Rao Bollineni
  • ISIN
  • INE967H01025

Similar Stocks to Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences FAQs

Krishna Institute of Medical Sciences share price is ₹661 As on 11 December, 2025 | 10:40

The Market Cap of Krishna Institute of Medical Sciences is ₹26475.2 Cr As on 11 December, 2025 | 10:40

The P/E ratio of Krishna Institute of Medical Sciences is 78.8 As on 11 December, 2025 | 10:40

The PB ratio of Krishna Institute of Medical Sciences is 13.2 As on 11 December, 2025 | 10:40

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23